Treatment of mycobacterium abscessus infection

Shannon A. Novosad, Susan E. Beekmann, Philip M. Polgreen, Kate Mackey, Kevin Winthrop

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.

Original languageEnglish (US)
Pages (from-to)511-514
Number of pages4
JournalEmerging Infectious Diseases
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology

Cite this

Novosad, S. A., Beekmann, S. E., Polgreen, P. M., Mackey, K., & Winthrop, K. (2016). Treatment of mycobacterium abscessus infection. Emerging Infectious Diseases, 22(3), 511-514. https://doi.org/10.3201/eid2203.150828